Recovery of ovarian function and pregnancy in a patient with AML after myeloablative busulphan-based conditioning regimen. [electronic resource]
Producer: 20110630Description: e154-5 p. digitalISSN:- 1536-3678
- Adolescent
- Antineoplastic Agents -- administration & dosage
- Busulfan -- administration & dosage
- Child
- Combined Modality Therapy
- Female
- Hematopoietic Stem Cell Transplantation
- Humans
- Hypogonadism -- drug therapy
- Leukemia, Myeloid, Acute -- drug therapy
- Myeloablative Agonists -- administration & dosage
- Ovary -- physiology
- Pregnancy
- Pregnancy Outcome
- Recovery of Function
- Transplantation Conditioning -- adverse effects
- Young Adult
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.